What's new

Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised

Apr 10, 2025 - 14:00
 0
Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised
Read More

Tags:

Previous Article

Disability advocates rally against Medicaid cuts

Next Article

Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tez...

Related Posts

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 21, 2025  0

EMEA-002963-PIP01-21-M01

EMEA-002963-PIP01-21-M01

Mar 6, 2025  0

Human medicines European public assessment report (EPAR): Supemtek Tetra (previously Supemtek), Quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 10, 2025  0